An antiviral pill developed by Merck & Co (MRK.N) could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, according to data that experts hailed as a potential breakthrough in how the virus is treated.
National News
Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
National News
JBS Australia set to impose restrictions at feedlots: All cattle will need to have a pre-entry vaccination on farm of the vaccine BOVILIS MH+IBR 14 to 180 days prior to delivery.
Cattle Network
Merck Animal Health to Acquire Assets of New Zealand Dairy Technology Company, LIC Automation Ltd.
World Ag News
Merck Animal Health Announces $270,000 In Scholarship Support To 54 Veterinary Students Around The World
AgToday
Morris Animal Foundation Receives $100K From Merck Animal Health to Support Animal Cancer Research
MERCK Animal Health
Vet Set Go and Merck Animal Health Team Up to Launch the “Become a Veterinarian Camp Contest 2021”
AgToday